HomeRVMD • NASDAQ
add
Revolution Medicines Inc
Previous close
$102.15
Day range
$100.52 - $104.32
Year range
$29.17 - $124.49
Market cap
20.24B USD
Avg Volume
2.76M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.05B | 3,635.79% |
Net income | -364.89M | -87.54% |
Net profit margin | — | — |
Earnings per share | -1.86 | -66.07% |
EBITDA | -358.49M | -67.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.03B | -11.52% |
Total assets | 2.35B | -7.97% |
Total liabilities | 723.21M | 146.75% |
Total equity | 1.63B | — |
Shares outstanding | 198.17M | — |
Price to book | 12.34 | — |
Return on assets | -39.25% | — |
Return on capital | -44.42% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -364.89M | -87.54% |
Cash from operations | -274.24M | -98.31% |
Cash from investing | 74.88M | 119.06% |
Cash from financing | 365.66M | -58.15% |
Net change in cash | 166.30M | -51.46% |
Free cash flow | -274.11M | -287.76% |
About
Founded
2014
Headquarters
Website
Employees
809
